Claims for Patent: 7,214,684
✉ Email this page to a colleague
Summary for Patent: 7,214,684
| Title: | Methods for the treatment of allergic rhinitis |
| Abstract: | Methods are disclosed utilizing DCL, a metabolic derivative of loratadine, for the treatment of allergic rhinitis, and other disorders, while avoiding the concomitant liability of adverse side-effects associated with other non-sedating antihistamines. |
| Inventor(s): | Aberg; A. K. Gunnar (Westborough, MA), McCullough; John R. (Worcester, MA), Smith; Emil R. (Shrewsbury, MA) |
| Assignee: | Sepracor Inc. (Marlborough, MA) |
| Application Number: | 10/989,514 |
| Patent Claims: |
1. A method of treating allergic rhinitis in a human comprising orally administering to a human a therapeutically effective amount of descarboethoxyloratadine, or a
pharmaceutically acceptable salt thereof, wherein the amount of the descarboethoxyloratadine administered is 0.1 mg to 5 mg per day.
2. The method of claim 1, wherein the amount of said descarboethoxyloratadine, or a pharmaceutically acceptable salt thereof, is administered together with a pharmaceutically acceptable carrier. |
